Can online therapy or parent coaching ease childhood anxiety? a head-to-head trial aims to find out.
NCT ID NCT07024758
First seen Jul 30, 2026 · Last updated Jul 31, 2026 · Updated 1 time
Summary
This trial compares two forms of cognitive-behavioral therapy (CBT) for children and teens with anxiety or obsessive-compulsive disorder (OCD). One approach uses internet-delivered modules with therapist guidance; the other trains parents to lead exposure exercises with their child. The goal is to see which method works better when in-person therapy is hard to access. About 174 youth aged 7 to 17 with significant anxiety or OCD symptoms will take part.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- cognitive-behavioral therapy delivered via internet modules or parent-coached exposure sessions
- What this could lead to
- If one approach proves more effective, it could expand access to proven anxiety treatments for children and teens, especially in areas with few therapists.
- What could go wrong
- This is a comparative effectiveness trial, not a test of a new drug; both therapies already show promise, but the study may find they work equally well or that one only helps certain families.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 174 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jul 2025
- Expected to finish
-
Jun 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
7 to 17 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * The child is between the ages of 7 to 17 years inclusive at enrollment. * The child has clinically significant symptoms of anxiety and/or OCD, as indicated by a score of 12 or higher on the Pediatric Anxiety Rating Scale (PARS). * The child is appropriate for anxiety-focused treatment (e.g., anxiety or OCD is the primary or co-primary problem as diagnosed using the DIAMOND-KID). * One parent/guardian is able and willing to participate in assessment and treatment (e.g., has sufficient English fluency, the decisional capacity to participate, and can commit to treatment duration). * The participating parent/guardian lives with their child at least 50% of the time per self-report. * Both parent and child can read and understand English. * The participant has an IQ above 69, based on the KBIT-2, another valid test or clinician judgement (e.g., a previous assessment conducted, and report shared with study team). * Participants must be in the state of Texas for treatment sessions/assessments. Exclusion Criteria: * The child has a diagnosis of a lifetime psychotic disorder and/or conduct disorder. * The child has significant, current and active suicidality/homicidality and/or self-injury requiring medical intervention. * The child has limited verbal communication abilities (e.g., no independent verbal communication). * The child is receiving concurrent psychotherapy with anxiety and/or OCD as the primary focus. They can pause ongoing therapy to enroll. * The child has initiated new antidepressant medication within 12-weeks of assessment (4-weeks for stimulants/benzodiazepines/antipsychotics) or during therapy. * The child has changed psychotropic medication dosage within 4-weeks of assessment (2-weeks for stimulants/benzodiazepines/antipsychotics) or during therapy. * The child requires a higher level of care than can be provided through the study (e.g., significant, current suicidal ideation).
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Anxiety disorder of childhood or adolescence are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Baylor College of Medicine
Houston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Gut bacteria may hold clues to dozens of diseases
- Magnetic brain zaps may quiet anxiety: device trial puts it to the test
- Can a computer game rewire anxious Kids' brains?
- Can a painless electrical acupoint zap boost OCD therapy?
- Can tailored brain stimulation quiet anxiety that drugs Can't?
- Can the right electric pulse calm chronic worry?